Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergiusz Markowicz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Poloniae Pharmaceutica|January 29, 2009
Harnessing stem cells and dendritic cells for novel therapiesSergiusz Markowicz
Journal of Proteomics|February 12, 2011
Proteomics for development of vaccineMonika Adamczyk-Poplawska, Sergiusz Markowicz, Elzbieta K Jagusztyn-Krynicka
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytesMagdalena Kowalewska, Magdalena Chechlińska, Sergiusz Markowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 30, 2015
Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracilAgnieszka Kotlarz, Małgorzata Przybyszewska, Paweł Swoboda, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 10, 2016
Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with DoxorubicinMałgorzata Przybyszewska, Joanna Miłoszewska, Agnieszka Kotlarz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 18, 2019
Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cellsAgnieszka Kotlarz, Małgorzata Przybyszewska, Paweł Swoboda, et al.
Acta Biochimica Polonica|January 13, 2006
Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapySergiusz Markowicz, Joanna Niedzielska, Marcin Kruszewski, et al.
Folia Neuropathologica|July 4, 2013
Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer propertiesJoanna Matalinska, Henryk Skurzak, Sergiusz Markowicz, et al.
Oncoimmunology|June 19, 2025
Cancer cells accelerate exhaustion of persistently activated mouse CD4<sup>+</sup> T cellsMalgorzata Stachowiak, William J Becker, Purevdorj B Olkhanud, et al.
International Journal of Molecular Sciences|June 18, 2016
The Effect of Analogues of 1α,25-Dihydroxyvitamin D₂ on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-FluorouracilJacek Neska, Paweł Swoboda, Małgorzata Przybyszewska, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Poloniae Pharmaceutica|January 29, 2009
Harnessing stem cells and dendritic cells for novel therapiesSergiusz Markowicz
Journal of Proteomics|February 12, 2011
Proteomics for development of vaccineMonika Adamczyk-Poplawska, Sergiusz Markowicz, Elzbieta K Jagusztyn-Krynicka
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytesMagdalena Kowalewska, Magdalena Chechlińska, Sergiusz Markowicz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 30, 2015
Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracilAgnieszka Kotlarz, Małgorzata Przybyszewska, Paweł Swoboda, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 10, 2016
Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with DoxorubicinMałgorzata Przybyszewska, Joanna Miłoszewska, Agnieszka Kotlarz, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 18, 2019
Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cellsAgnieszka Kotlarz, Małgorzata Przybyszewska, Paweł Swoboda, et al.
Acta Biochimica Polonica|January 13, 2006
Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapySergiusz Markowicz, Joanna Niedzielska, Marcin Kruszewski, et al.
Folia Neuropathologica|July 4, 2013
Opioid agonist--tachykinin antagonist as a new analgesic with adjuvant anticancer propertiesJoanna Matalinska, Henryk Skurzak, Sergiusz Markowicz, et al.
Oncoimmunology|June 19, 2025
Cancer cells accelerate exhaustion of persistently activated mouse CD4<sup>+</sup> T cellsMalgorzata Stachowiak, William J Becker, Purevdorj B Olkhanud, et al.
International Journal of Molecular Sciences|June 18, 2016
The Effect of Analogues of 1α,25-Dihydroxyvitamin D₂ on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-FluorouracilJacek Neska, Paweł Swoboda, Małgorzata Przybyszewska, et al.
Pageof 2